PCM
Perkins Capital Management’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $572K | Sell |
27,995
-5,970
| -18% | -$122K | 0.57% | 44 |
|
|
2025
Q1 | $680K | Sell |
33,965
-200
| -0.6% | -$4K | 0.72% | 44 |
|
|
2024
Q4 | $910K | Buy |
34,165
+1,525
| +5% | +$40.6K | 0.81% | 41 |
|
|
2024
Q3 | $931K | Buy |
32,640
+1,550
| +5% | +$44.2K | 0.87% | 37 |
|
|
2024
Q2 | $677K | Sell |
31,090
-1,050
| -3% | -$22.9K | 0.64% | 47 |
|
|
2024
Q1 | $712K | Hold |
32,140
| – | – | 0.59% | 51 |
|
|
2023
Q4 | $694K | Buy |
32,140
+2,980
| +10% | +$64.3K | 0.59% | 52 |
|
|
2023
Q3 | $493K | Sell |
29,160
-1,425
| -5% | -$24.1K | 0.49% | 59 |
|
|
2023
Q2 | $420K | Sell |
30,585
-525
| -2% | -$7.21K | 0.37% | 64 |
|
|
2023
Q1 | $707K | Hold |
31,110
| – | – | 0.67% | 48 |
|
|
2022
Q4 | $732K | Hold |
31,110
| – | – | 0.77% | 39 |
|
|
2022
Q3 | $811K | Sell |
31,110
-2,060
| -6% | -$53.7K | 0.91% | 37 |
|
|
2022
Q2 | $728K | Hold |
33,170
| – | – | 0.75% | 48 |
|
|
2022
Q1 | $1.49M | Hold |
33,170
| – | – | 1.22% | 32 |
|
|
2021
Q4 | $1.42M | Buy |
33,170
+20
| +0.1% | +$857 | 0.96% | 37 |
|
|
2021
Q3 | $2.2M | Hold |
33,150
| – | – | 1.36% | 25 |
|
|
2021
Q2 | $2.43M | Sell |
33,150
-350
| -1% | -$25.7K | 1.38% | 26 |
|
|
2021
Q1 | $2.29M | Sell |
33,500
-1,000
| -3% | -$68.4K | 1.33% | 26 |
|
|
2020
Q4 | $2.32M | Sell |
34,500
-400
| -1% | -$26.9K | 1.52% | 19 |
|
|
2020
Q3 | $1.8M | Buy |
+34,900
| New | +$1.8M | 1.65% | 19 |
|
|
2020
Q1 | $1.01M | Buy |
33,850
+6,455
| +24% | +$192K | 1.22% | 28 |
|
|
2019
Q4 | $942K | Sell |
27,395
-525
| -2% | -$18.1K | 0.84% | 41 |
|
|
2019
Q3 | $505K | Buy |
+27,920
| New | +$505K | 0.44% | 69 |
|